Characterization of RBD-specific cross-neutralizing antibodies responses against SARS-CoV-2 variants from COVID-19 convalescents

INTRODUCTION: The novel severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) pandemic has been posing a severe threat to global public health. Although broadly neutralizing antibodies have been used to prevent or treat corona virus disease 2019 (COVID-19), new emerging variants have been pro...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Zheng, Li, Dan, Chen, Yulu, Sun, Yeping, Jin, Changzhong, Hu, Caiqin, Feng, Yi, Su, Junwei, Ren, Li, Hao, Yanling, Wang, Shuo, Zhu, Meiling, Liu, Ying, Qi, Jianxun, Zhu, Biao, Shao, Yiming
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Immunology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10207940/
https://www.ncbi.nlm.nih.gov/pubmed/37234155
http://dx.doi.org/10.3389/fimmu.2023.1160283

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10207940/
https://www.ncbi.nlm.nih.gov/pubmed/37234155
http://dx.doi.org/10.3389/fimmu.2023.1160283

Ejemplares similares